An observational study in Sudden Cardiac Death and Cardiac Arrhythmias, sponsored by University of Sao Paulo. Not yet recruiting at 1 site in Brazil. Open to participants aged 5 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.
Sponsored by University of Sao Paulo · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Sports participation is strongly encouraged in children and adolescents, but intense training at early ages may reveal hidden heart conditions that increase the risk of sudden cardiac death. Pre-participation evaluation aims to identify these conditions before sports practice.
This observational study will evaluate children and adolescents enrolled in the São Paulo Olympic Program (Programa São Paulo Olímpico). All participants will undergo a structured medical interview, a standardized physical examination and a resting 12-lead electrocardiogram (ECG). Participants with borderline ECG findings, warning symptoms, abnormal physical examination findings or a suggestive personal or family history will also undergo a 3-minute step test (Harvard step test) with continuous ECG recording during exercise and recovery, in order to detect exercise-induced arrhythmias.
The main goal is to estimate the prevalence of potentially pathological ECG findings in this population. The study will also describe warning signs in the medical history, abnormal physical examination findings, step test results, and the referrals and confirmed diagnoses during follow-up.
Background
Sports practice in childhood and adolescence brings physical, psychological and social benefits. However, the cardiovascular demands of exercise may reveal or worsen latent conditions that, if unrecognized, can lead to adverse events, including sudden cardiac death (SCD). Pre-participation evaluation (PPE) is a screening tool designed to detect such conditions and usually includes medical and family history, physical examination and, in some protocols, a resting electrocardiogram (ECG). The ECG increases the sensitivity for arrhythmogenic cardiomyopathies, channelopathies and other electrical abnormalities that may be missed by clinical examination alone. Its routine use in minors remains controversial: European recommendations support routine ECG in young athletes, while North American organizations recommend a selective approach. There is limited evidence on the effectiveness and applicability of these protocols in pediatric populations.
Exercise-induced arrhythmias may not be detected on a resting ECG. A recent clinical consensus statement of the European Association of Preventive Cardiology (EAPC) and the Association for European Paediatric and Congenital Cardiology (AEPC) considers a continuous 3-minute step test with ECG recording during exercise and after abrupt cessation, followed by 3 minutes of post-exercise monitoring, a valid, low-cost and widely available alternative to rule out exercise-induced arrhythmias in pediatric athletes.
Study design and setting
Prospective observational study conducted at the Heart Institute (Instituto do Coração, InCor), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, Brazil, including children and adolescents enrolled in organized sports in the São Paulo Olympic Program.
Procedures
Step test (second-tier evaluation): performed in participants with any of the following: borderline ECG findings (abnormal axis deviation, atrial enlargement, first-degree AV block with PR 200-280 ms, complete right bundle branch block, borderline T-wave inversion in V1-V4 at ages 12-14 years, low QRS voltage, Mobitz type I second-degree AV block); warning symptoms (exertional syncope or near-syncope, palpitations during or after exercise, disproportionate dyspnea, exertional chest pain); abnormal physical examination (heart murmur grade 2/6 or higher, arrhythmia on auscultation, elevated blood pressure or abnormal pressure response); or suggestive history (family history of sudden cardiac death before 50 years of age, previous myocarditis, family history of long or short QT syndrome).
Step test protocol: fixed-height step of 45 cm (30 cm for children younger than 12 years). After a supine baseline ECG, the test includes 1 minute of seated rest with continuous 12-lead ECG; 3 minutes of continuous stepping at a standardized cadence with continuous ECG recording; abrupt cessation with the participant seated and continuous 12-lead ECG during the first 3 minutes of recovery; and 3 to 5 additional minutes of monitoring with final clinical examination. Heart rate, rhythm, ST segment, T wave, QTc, symptoms, blood pressure and oxygen saturation will be recorded. The test will not be performed in the presence of fever or acute symptoms in the previous 72 hours, recent confirmed or suspected myocarditis (within 3-6 months), unexplained syncope in the previous week, known severe structural heart disease without cardiologist clearance, resting heart rate above 120 bpm or elevated resting blood pressure, clinical instability or chest pain at rest, known pregnancy, or refusal by the participant or legal guardian. The test will be stopped immediately in case of chest pain, syncope, evident intolerance or significant ECG changes. Results will be classified as normal, borderline or abnormal. The test will be supervised by a physician (cardiologist or trained pediatrician) with an ECG technician, in a clinical setting with basic life support available.
Quality control
Training of the study team, a pilot with 20-30 athletes (including 5-10 step tests), random re-evaluation of 10% of ECGs and clinical forms, and calculation of interobserver agreement (kappa) for ECG categories.
Statistical analysis
Continuous variables will be described as mean and standard deviation or median and interquartile range, and categorical variables as frequencies and percentages. Prevalence will be estimated with 95% confidence intervals (CI). Comparisons will use chi-square or Fisher's exact test for categorical variables and Student's t test or Mann-Whitney test for continuous variables, according to distribution (Shapiro-Wilk test). Multivariable logistic regression will identify factors associated with potentially pathological findings, adjusted for age, sex, sport, training load and pubertal stage when available. Missing data will be addressed by sensitivity analysis, with multiple imputation if more than 5% of key covariates are missing. Significance level: alpha = 0.05 (two-tailed). Additional analyses for the step test include the proportion of indicated versus performed tests, prevalence of abnormal results, agreement between resting ECG and step test findings (kappa), correlation between type of ECG finding and step test result, and cost-effectiveness.
Sample size
Assuming a 95% confidence level, an expected arrhythmia prevalence of 3.6% and an absolute precision of 2 percentage points, the minimum sample size is 334 participants.
364 studies on the registry are indexed under Death, Sudden, Cardiac; 84 are open to participants now.
This study's planned enrollment of 334 is below the median of 450 across 203 observational studies indexed under Death, Sudden, Cardiac.
Browse Death, Sudden, Cardiac studies →University of Sao Paulo is the lead sponsor of 1,036 studies on the registry; 96 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Children and adolescents younger than 18 years regularly enrolled in organized sports in the São Paulo Olympic Program, with at least two training sessions per week, evaluated at the Heart Institute (InCor), São Paulo, Brazil.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Children and adolescents younger than 18 years enrolled in organized sports in the São Paulo Olympic Program, undergoing cardiovascular pre-participation evaluation. Participants meeting predefined clinical or electrocardiographic criteria also undergo a step test.
Other: Pre-participation clinical evaluation · Diagnostic Test: Diagnostic Test: Resting 12-lead electrocardiogram · Diagnostic Test: Diagnostic Test: Step test (Harvard step test)
Structured cardiovascular medical history and standardized physical examination.
Resting 12-lead electrocardiogram (ECG) analyzed independently by two blinded sports cardiologists.
3-minute continuous step test with electrocardiogram (ECG) recording during exercise and recovery, performed only in participants with borderline ECG findings, warning symptoms, abnormal physical examination or suggestive personal or family history.
Prevalence of potentially pathological findings on resting electrocardiogram
Proportion of participants whose resting 12-lead electrocardiogram (ECG) is classified as potentially pathological by two independent sports cardiologists blinded to clinical data, according to the study's operational classification
Time frame: At the pre-participation evaluation (day 1)
Prevalence of warning signs and symptoms in the medical history
Proportion of participants reporting cardiovascular warning symptoms or a relevant personal or family history in the structured questionnaire.
Time frame: At the pre-participation evaluation (day 1)
Prevalence of abnormal physical examination findings
Proportion of participants with abnormal cardiovascular findings on standardized physical examination, including pathological murmurs, elevated blood pressure, abnormal pulses and Marfan phenotype.
Time frame: At the pre-participation evaluation (day 1)
Odds ratio of potentially pathological electrocardiogram findings by age
Odds ratio, with 95% confidence interval, for a resting 12-lead electrocardiogram (ECG) classified as potentially pathological per 1-year increase in age, estimated by multivariable logistic regression adjusted for sex, sport and training load.
Time frame: At the pre-participation evaluation (day 1)
Odds ratio of potentially pathological electrocardiogram findings by sex
Odds ratio, with 95% confidence interval, for a resting 12-lead electrocardiogram (ECG) classified as potentially pathological in male versus female participants, estimated by multivariable logistic regression adjusted for age, sport and training load.
Time frame: Up to 30 days after the pre-participation evaluation
Odds ratio of potentially pathological electrocardiogram findings by sport
Odds ratio, with 95% confidence interval, for a resting 12-lead electrocardiogram (ECG) classified as potentially pathological according to sport category, estimated by multivariable logistic regression adjusted for age, sex and training load.
Time frame: Up to 30 days after the pre-participation evaluation
Odds ratio of potentially pathological electrocardiogram findings by training load
Odds ratio, with 95% confidence interval, for a resting 12-lead electrocardiogram (ECG) classified as potentially pathological per 1-hour increase in weekly training load, estimated by multivariable logistic regression adjusted for age, sex and sport.
Time frame: Up to 6 months
Rate of confirmed cardiovascular diagnoses
Proportion of referred participants with a confirmed cardiovascular diagnosis after specialized evaluation.
Time frame: 3 to 6 months after the pre-participation evaluation
Start is estimated for Feb 2027; primary completion for Dec 2027, 10 months later.
Of 70 non-industry observational studies under Death, Sudden, Cardiac, half reached primary completion within 74 months of starting (the median), counting those still running; a quarter within 42. This study's planned 10 months is below that.
Counting every sponsor, half of 86 studies reached it within 63 months; a quarter within 40.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.